Status:

COMPLETED

Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057

Lead Sponsor:

Masimo Corporation

Conditions:

Healthy

Atrial Fibrillation

Eligibility:

All Genders

22+ years

Phase:

NA

Brief Summary

The objective of this study is to validate the performance of the electrocardiogram (ECG) function of the Masimo INVSENSOR00057 against contemporaneous measurements

Eligibility Criteria

Inclusion

  • Subject is 22 years of age or older
  • Subject is comfortable to read and communicate in English\*
  • Subject belongs to one of two groups:
  • Subjects without any prior arrhythmia diagnosis presenting in normal sinus rhythm (Group1)
  • Subjects with history of paroxysmal or persistent atrial fibrillation presenting in atrial fibrillation (Group 2) \*This is to ensure the subject can provide informed consent (as Masimo INVSENSOR00057 ECG study materials are currently available in English only) and can comply with study procedures.

Exclusion

  • Subjects who are physically unable to wear a wristwatch
  • Subjects whose skin is not intact (e.g., has open wounds, has inflamed tattoos or piercings, has visible healing wounds) in or at the vicinity of the device placement site.
  • Subjects with an implantable defibrillator or cardiac pacing device.
  • Subjects with a skin condition which would preclude proper ECG electrode placement..
  • Subjects with known allergic reactions to adhesive tapes or ECG gel.
  • Subjects previously diagnosed with non-atrial fibrillation cardiac arrhythmia.
  • Subjects not suitable for the investigation at the discretion of the investigator or the clinical team

Key Trial Info

Start Date :

September 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 30 2024

Estimated Enrollment :

365 Patients enrolled

Trial Details

Trial ID

NCT06071754

Start Date

September 1 2023

End Date

April 30 2024

Last Update

October 31 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Masimo Clinical Lab

Irvine, California, United States, 92618

2

PCA Cardiology

Laguna Hills, California, United States, 92653

3

Cone Health

Greensboro, North Carolina, United States, 27401

4

Medication Management

Greensboro, North Carolina, United States, 27405